Allogeneic transplantation for CML in the TKI era: striking the right balance.
about
Chronic myeloid leukemia: reminiscences and dreamsTyrosine kinase inhibitors in chronic myeloid leukaemia: which, when, for whom?A safety evaluation of omacetaxine mepesuccinate for the treatment of chronic myeloid leukemia.Hematopoietic Stem Cell Transplantation: A Bioethical Lens.CXorf48 is a potential therapeutic target for achieving treatment-free remission in CML patients.The role of allogeneic hematopoietic stem cell transplantation in the four P medicine era.
P2860
Allogeneic transplantation for CML in the TKI era: striking the right balance.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Allogeneic transplantation for CML in the TKI era: striking the right balance.
@en
type
label
Allogeneic transplantation for CML in the TKI era: striking the right balance.
@en
prefLabel
Allogeneic transplantation for CML in the TKI era: striking the right balance.
@en
P2093
P2860
P1476
Allogeneic transplantation for CML in the TKI era: striking the right balance.
@en
P2093
Andrew J Innes
Dragana Milojkovic
Jane F Apperley
P2860
P356
10.1038/NRCLINONC.2015.193
P407
P577
2015-11-17T00:00:00Z